134 related articles for article (PubMed ID: 54310)
1. The preparation of the factors IX, II, and X concentrate by means of DEAE cellulos and its therapeutic effectiveness.
Uszyński L; Poszwiński P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(5):591-4. PubMed ID: 54310
[TBL] [Abstract][Full Text] [Related]
2. A therapeutic concentrate of coagulation factors II, IX and X from citrated, factor VIII-depleted plasma.
Middleton SM; Bennett IH; Smith JK
Vox Sang; 1973 May; 24(5):441-56. PubMed ID: 4691239
[No Abstract] [Full Text] [Related]
3. The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X and of a separate concentrate containing factor VII.
Dike GW; Bidwell E; Rizza CR
Br J Haematol; 1972 Apr; 22(4):469-90. PubMed ID: 4112845
[No Abstract] [Full Text] [Related]
4. [The P.P.S.B. coagulant fraction].
Soulier JP; Steinbuch M
Nouv Presse Med; 1975 Oct; 4(36):2581-4. PubMed ID: 812061
[No Abstract] [Full Text] [Related]
5. [Preparation of factor IX concentrate with the use of DEAE-cellulose and its therapeutic results].
Uszyński L; Poszwiński P
Acta Haematol Pol; 1971; 2(2):109-14. PubMed ID: 5170671
[No Abstract] [Full Text] [Related]
6. Purification of human factor IX by chromatography of a coagulation factor concentrate.
Suomela H
Thromb Haemost; 1976 Feb; 35(1):211-21. PubMed ID: 989188
[TBL] [Abstract][Full Text] [Related]
7. [A human plasma fraction (PPSB) enriched with the coagulation factors II, VII, IX and X].
Richter K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):340-3. PubMed ID: 4195279
[No Abstract] [Full Text] [Related]
8. The adsorption of blood coagulation factors II, VII, IX and X from human plasma to aluminium hydroxide.
Swart AC; Klaassen BH; Bloys-van Treslong-de ; Hemker HC
Thromb Diath Haemorrh; 1972 Jul; 27(3):490-501. PubMed ID: 4662612
[No Abstract] [Full Text] [Related]
9. Prothrombin complex concentrates: preparation, properties, and clinical uses.
White GC; Lundblad RL; Kingdon HS
Curr Top Hematol; 1979; 2():203-44. PubMed ID: 318075
[No Abstract] [Full Text] [Related]
10. Improved procedures for the purification of selected vitamin K-dependent proteins.
Novoa E; Seegers WH; Hassouna HI
Prep Biochem; 1976; 6(5):307-38. PubMed ID: 787972
[TBL] [Abstract][Full Text] [Related]
11. A simplified procedure for purification of human prothrombin, factor IX and factor X.
Bajaj SP; Rapaport SI; Prodanos C
Prep Biochem; 1981; 11(4):397-412. PubMed ID: 7312833
[TBL] [Abstract][Full Text] [Related]
12. The separation of clotting factors II (prothrombin) and IX (plasma thromboplastin component) by isoelectric focusing.
Pechet L; Smith JA
Biochim Biophys Acta; 1970 Mar; 200(3):475-85. PubMed ID: 4985341
[No Abstract] [Full Text] [Related]
13. Development of large-scale fractionation methods. II. Isolation of a factor IX concentrate (prothrombin complex) for clinical use.
Wickerhauser M; Sgouris JT
Vox Sang; 1972; 22(2):137-60. PubMed ID: 5013242
[No Abstract] [Full Text] [Related]
14. [A factor IX-concentrate for the treatment of haemophilia B].
Suomela H; Myllylä G
Duodecim; 1971; 87(1):31-8. PubMed ID: 5539580
[No Abstract] [Full Text] [Related]
15. Plasma free of factors II, VII, IX, and X. Need for high speed centrifugation after Al(OH) 3 absorption.
Loeliger EA; van Halem-Visser LP; Hemker HC
Thromb Diath Haemorrh; 1973 Feb; 29(1):211-2. PubMed ID: 4708596
[No Abstract] [Full Text] [Related]
16. Surgical operation in hemophilia B. Use of factor IX concentrate.
Kasper CK
Calif Med; 1970 Jul; 113(1):4-8. PubMed ID: 5520728
[TBL] [Abstract][Full Text] [Related]
17. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
[TBL] [Abstract][Full Text] [Related]
18. A procedure for isolation of human protein C and protein S as by-products of the purification of factors VII, IX, X and prothrombin.
Bajaj SP; Rapaport SI; Maki SL; Brown SF
Prep Biochem; 1983; 13(3):191-214. PubMed ID: 6226944
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and clinical use of a new factor IX concentrate].
Lopaciuk S; Poszwiński P
Acta Haematol Pol; 1978; 9(2):107-12. PubMed ID: 665130
[TBL] [Abstract][Full Text] [Related]
20. Heat treated New Zealand factor IX concentrate: comparison with Prothrombinex in patients with haemophilia B.
Benny AG; Ockelford PA; Johns AS; Woodfield DG; Berry EW
N Z Med J; 1986 Jun; 99(803):408-9. PubMed ID: 3461352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
